Earlier this year, the Social Security Administration (SSA) announced plans to shift responsibility for medical Continuing Disability Reviews (CDRs) from state Disability Determination Services (DDS) agencies to SSA’s federal Disability Case Review (DCR) component. CDRs are periodic reviews to determine whether a person receiving disability benefits continues to meet SSA’s medical eligibility requirements. See 20 C.F.R. §§ 404.1590, 416.990.
As reported in the April issue of this newsletter, the announcement raised unanswered operational questions that were later tempered by indications that implementation would occur gradually and would likely be tied to fiscal year 2027 rather than an immediate nationwide transition.
With the shift now seemingly underway, questions about the plan are now drawing congressional scrutiny. On August 6, 2026, Rep. John B. Larson, Ranking Member of the House Social Security Subcommittee, and Rep. Danny K. Davis, Ranking Member of the Worker and Family Support Subcommittee, announced that they requested an independent review by the Government Accountability Office (GAO) of SSA’s decision to federalize medical CDRs.
In their request, the lawmakers asked GAO to examine whether SSA established clear goals and expected outcomes for the initiative, developed a plan to evaluate its effectiveness, and assessed the impact of the change on processing times, accuracy, backlogs, administrative costs, beneficiaries, and state DDS capacity. They also requested information about how SSA would measure success and whether the agency has modified its approach based on any early findings.
According to the letter, SSA conducts approximately 1.4 million CDRs annually to determine whether beneficiaries remain medically eligible. While CDRs are an important program integrity tool, changes to how those reviews are administered could have substantial consequences for beneficiaries and for state DDS operations.
SSA has maintained that centralizing medical CDRs under federal management will provide greater accountability and permit DDS agencies to devote more resources to reducing disability application and reconsideration backlogs. The agency has emphasized that the change does not alter the legal standards governing eligibility for disability benefits.
SSA has undergone sweeping organizational change since 2025; some of the more recent restructuring was discussed in the October 2025 and January 2026 issues of this newsletter. The shift to centralized federal management of CDRs is accompanied by an expansion of this workload. In budget materials for the fiscal year that just ended on September 30, 2026, SSA indicated that additional program-integrity investments and operational changes could support approximately 200,000 additional CDRs while helping eliminate the agency’s longstanding CDR backlog. Advocates in New York have already reported an increase in CDR cases.
Congressional oversight of the proposal is likely to continue as SSA implements its plans and as the CDR workload appears to expand significantly. Whether federalization ultimately improves efficiency remains an open question, and the results of any future GAO investigation could help inform that debate.